Category: Press Release - Page 134 - Psychedelic Alpha

Part 3 of our Year in Review video series is out now.

Read more about the article Awakn Life Sciences Initiates New Chemical Entity Development Program with Evotec as Research Partner and Addiction Expert, Prof. David Nutt, as Program Lead

Awakn Life Sciences Initiates New Chemical Entity Development Program with Evotec as Research Partner and Addiction Expert, Prof. David Nutt, as Program Lead

Post published:April 27, 2021
Post category:Press Release

Read more about the article MINDCURE Announces Partnership with SOMA Breath Inc. to License its Breathwork Program and Develop Custom Breathwork for Psychedelic-Assisted Psychotherapies within iSTRYM

MINDCURE Announces Partnership with SOMA Breath Inc. to License its Breathwork Program and Develop Custom Breathwork for Psychedelic-Assisted Psychotherapies within iSTRYM

Post published:April 27, 2021
Post category:Press Release

Read more about the article MindMed Begins Trading on Nasdaq

MindMed Begins Trading on Nasdaq

Post published:April 27, 2021
Post category:Press Release

Read more about the article Psyched Wellness Initiates the Next Pre-Clinical Trial Study on AME-1

Psyched Wellness Initiates the Next Pre-Clinical Trial Study on AME-1

Post published:April 27, 2021
Post category:Press Release

Read more about the article PharmaTher Expands Patent Portfolio with Filing of U.S. Patent Application for Ketamine and Repurposing of Psychedelics with panaceAI™

PharmaTher Expands Patent Portfolio with Filing of U.S. Patent Application for Ketamine and Repurposing of Psychedelics with panaceAI™

Post published:April 27, 2021
Post category:Press Release

Read more about the article PsyBio and Miami University Broaden Partnership Agreement for the Continued Advancement of its Neuropsychiatric Drug Discovery Platform, Expediting its IND Submission to the FDA

PsyBio and Miami University Broaden Partnership Agreement for the Continued Advancement of its Neuropsychiatric Drug Discovery Platform, Expediting its IND Submission to the FDA

Post published:April 26, 2021
Post category:Press Release

Read more about the article Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003

Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003

Post published:April 26, 2021
Post category:Press Release

Read more about the article Mydecine to Report Full Year 2020 Financial Results on May 3, 2021

Mydecine to Report Full Year 2020 Financial Results on May 3, 2021

Post published:April 26, 2021
Post category:Press Release

Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction Prepared at Company Lab

Post published:April 26, 2021
Post category:Press Release

Read more about the article Red Light Holland and Headland West Indies Lead #SVGStrong, a Relief Effort in St. Vincent and the Grenadines

Red Light Holland and Headland West Indies Lead #SVGStrong, a Relief Effort in St. Vincent and the Grenadines

Post published:April 23, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.